Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
07/10/2020 - 18:22
DIASORIN
Informativa settimanale acquisto azioni proprie
07/10/2020 - 16:13
DIASORIN
Notice availability Shareholders' meeting minutes June 10, 2020
07/10/2020 - 16:11
DIASORIN
Avviso disponibilita' verbale Assemblea degli Azionisti 10 giugno 2020
07/09/2020 - 07:27
DIASORIN
DiaSorin will provide the UK Government with its LIAISON SARS-CoV-2 S1/S2 IgG serology kit for COVID-19 testing to run a national screening study
07/09/2020 - 07:25
DIASORIN
DiaSorin fornirà al Regno Unito il test sierologico LIAISON SARS-CoV-2 S1/S2 IgG per il completamento di uno screening della popolazione
07/07/2020 - 07:22
DIASORIN
DiaSorin CE marks their new Simplexa Flu A/B & RSV Direct Gen II Assay to run with the Simplexa COVID-19 Direct assay
07/07/2020 - 07:20
DIASORIN
DiaSorin lancia il nuovo test Simplexa Flu A/B & RSV Direct Gen II marcato CE, eseguibile in combinazione con il test Simplexa COVID-19 Direct
06/30/2020 - 07:26
DIASORIN
DiaSorin announces the launch of its new LIAISON SARS-COV-2 IgM test, a new fully automated serology kit
06/30/2020 - 07:24
DIASORIN
DiaSorin lancia il LIAISON SARS-CoV-2 IgM in Europa e negli Stati Uniti, un nuovo test sierologico automatizzato
06/19/2020 - 17:20
DIASORIN
Weekly report treasury shares buy-back
06/19/2020 - 17:19
DIASORIN
Informativa settimanale acquisto azioni proprie
06/17/2020 - 16:09
DIASORIN
Start up of treasury shares buy-back plan
06/17/2020 - 16:06
DIASORIN
Avvio programma di acquisto azioni proprie
06/12/2020 - 07:28
DIASORIN
DiaSorin has CE marked its molecular's Simplexa™ Congenital CMV Direct Assay
06/12/2020 - 07:27
DIASORIN
DiaSorin ha marcato CE il proprio test molecolare Simplexa™ Congenital CMV Direct
06/10/2020 - 15:40
DIASORIN
Shareholders' Meeting June 10, 2020
06/10/2020 - 15:39
DIASORIN
Assemblea degli Azionisti 10 giugno 2020
06/03/2020 - 14:15
DIASORIN
The LIAISON® SARS-CoV-2 S1 S2 IgG test receives the approval from ANVISA in Brazil
06/03/2020 - 14:14
DIASORIN
Il test sierologico LIAISON® SARS-CoV-2 S1 S2 IgG riceve l'approvazione da ANVISA per il mercato brasiliano
06/02/2020 - 15:00
DIASORIN
Communication voting rights amount
06/02/2020 - 14:58
DIASORIN
Comunicazione ammontare complessivo diritti di voto
05/18/2020 - 11:26
DIASORIN
DIASORIN - THE LIAISON® SARS-COV-2 S1S2 IGG TEST IS THE FIRST TO RECEIVE THE APPROVAL FROM HEALTH CANADA
05/18/2020 - 11:24
DIASORIN
DIASORIN - IL TEST SIEROLOGICO LIAISON® SARS-COV-2 S1S2 IGG È IL PRIMO A RICEVERE L’APPROVAZIONE DA HEALTH CANADA
05/13/2020 - 13:12
DIASORIN
DiaSorin - Q1 2020 results

Pagination

  • First page « First
  • Previous page ‹ Precedente
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Current page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are